| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q4 2024 |
FY 2024 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2024 |
FY 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$8,912,022 |
USD |
42% |
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Valuation Allowance |
$1,626,832 |
USD |
127% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$201,872 |
USD |
-42% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
$57,517 |
USD |
-93% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid |
$59,414 |
USD |
-93% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability, Current |
$27,588 |
USD |
-87% |
Q2 2025 |
Q2 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$5,817 |
USD |
-98% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$53,597 |
USD |
|
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$1,897 |
USD |
-98% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$1,706,177 |
USD |
63% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$25,160,161 |
USD |
0.4% |
Q2 2024 |
Q2 2024 |
| Deferred Tax Assets, Net of Valuation Allowance |
$1,626,832 |
USD |
127% |
Q4 2024 |
FY 2024 |